Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of AI201901 in Allergic Rhinitis (HILARIA)
NCT04729517Phase 3Completed
- Sponsor
- Abdi İbrahim
- Start
- Apr 2021
- Primary completion
- Mar 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of AI201901 in allergic rhinitis (AR), sponsored by Abdi İbrahim. Started Apr 2021; status: completed.
02
Drugs
AI201901
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT04729517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04729517.